MarketLens
Sign Up

Assertio's Acquisition: What's the Deal and Why Now

4 months ago
SHARE THIS ON:

Assertio's Acquisition: What's the Deal and Why Now

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•3 weeks ago

Should You Buy Jazz Pharmaceuticals Stock After Its Actio Acquisition?

Jazz Pharmaceuticals paid $820M upfront to acquire Actio Biosciences, with Actio shareholders eligible for up to $500M more in milestone payments. The deal adds pipeline assets but raises near-term ca...
Stock News•2 months ago

AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus

AstraZeneca and Bristol Myers Squibb are in potential merger talks to form a ~$400B pharma giant, per weekend media reports. Deal economics and patent expirations are now in focus for investors.
Stock News•2 months ago

argenx SE (ARGX) M&A Call Transcript

Argenx SE held an M&A call. The transcript details the company's strategic rationale and potential financial implications of the transaction.

Breaking News

View All →

Top Headlines

View More →
Stock News•4 hours ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•5 hours ago

Is It Too Late to Buy Palantir Stock?

Stock News•6 hours ago

1 Reason the Meta Muse AI Agent Has the Upper Hand

Stock News•7 hours ago

AI Revenue Questions Pull Semiconductor Stocks Off October Highs

Stock News•8 hours ago

Like Meta's Muse AI Agents? 4 AI Semiconductor Stocks Set to Benefit From the Rise of AI Agents.